Related Experiment Video
Updated: May 26, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
ACEI associated angioedema - a case study and review
Nick Andrew1, Genevieve Gabb, Matthew Del Fante
1Department of Medicine, Royal Adelaide Hospital, South Australia, Australia. nick.h.andrew@gmail.com
Background:
Angioedema is an infrequent but potentially serious adverse effect of angiotensin converting enzyme inhibitors (ACEIs).
Objective:
This article describes a case of ACEI associated angioedema and reviews important clinical features of the condition.
Discussion:
The mechanism of ACEI associated angioedema is not allergic (histamine mediated), but rather due to an alteration of the balance of bradykinin and other vasodilator mediators. Onset may be delayed for weeks, months or years and episodes may be recurrent. Occasionally, airway obstruction may occur. Diagnosis is from history and physical examination; there is no specific diagnostic test. In contrast to allergic angioedema, ACEI associated angioedema is generally unresponsive to corticosteroids and antihistamines, although these agents are often used by convention. In the longer term, cessation of the ACEI is necessary to reduce the risk of recurrent episodes.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Aortic Regurgitation I: Introduction
Aneurysm I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Aneurysm III: Interprofessional Care

